Connect with us

Headlines

Eyecare Centers Report Data Breach

They fell victim to malware.

mm

Published

on

SWANSEA, IL — JFJ Eyecare Ltd., doing business as Quantum Vision Centers and Eye Surgery Center LLC, announced that some of its systems were accessed by an unauthorized person.

“While there is no evidence that suggests that any data was actually taken, Quantum Vision Centers and Eye Surgery Center have mailed letters to individuals whose information may have been affected,” the company stated in a press release.

On April 18, Quantum Vision Centers and Eye Surgery Center “became aware of an incident in which malware was introduced by an unauthorized person into some of their systems,” according to the release.

The malware encrypted certain files, including on a server that contained patient protected health information. The types of affected data may include first and last name, date of birth, address, social security number and information relating to health insurance coverage.

“There is currently no evidence that suggests this malware incident actually resulted in the acquisition of any personal information beyond its encryption, but that possibility cannot be conclusively ruled out,” the company stated.

Quantum Vision Centers and Eye Surgery Center have taken steps including “working diligently to contain the promulgation of the malware, and engaging a third-party forensics firm to investigate the scope and source of the incident.” They also deployed backup measures to recover the data that had been encrypted by the malware and to ensure that the services to patients could continue with limited interruption.

Advertisement

“Quantum Vision Centers and Eye Surgery Center continue to work on ways to mitigate the risk of future such incidents,” according to the release. “Out of an abundance of caution, they are providing patients that may have been affected by this incident with one year of credit monitoring services at no cost to them.”

Quantum Vision Centers and Eye Surgery Center encourage patients to remain vigilant over the coming months and regularly review their bank and other financial account statements, as well as their credit report. Patients that have any reason to believe that they may be the victim of identity theft, or notice any suspicious activity on any of their accounts, should immediately notify the relevant institution, their local law enforcement agency, their state’s Attorney General and the Federal Trade Commission.

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at editor@invisionmag.com.

Advertisement

SPONSORED VIDEO

SPONSORED BY KENMARK

Jump In — the Water’s Fine!

With a salute to summer’s shimmery, mermaid colors and warm weather-loving shades, Kenmark Eyewear celebrates this summer’s Aloha spirit with eyewear from Vera Wang, Kensie, Zac Posen and the Original Penguin Collection!

Promoted Headlines

Headlines

Japanese Women Seek Right to Wear Eyeglasses at Work

Some companies require female workers to wear contacts instead.

mm

Published

on

Women in Japan are calling for an end to company policies that forbid them from wearing eyeglasses, Fortune reports.

The issue appeared in the news recently, with Nippon TV reporting on companies that have such a ban in place, requiring female employees who need vision correction to wear contact lenses instead. That report sparked the hashtag “glasses ban” on Twitter.

Fortune quoted Banri Yanagi, a 40-year-old sales associate in Tokyo, saying, “The emphasis on appearance is often on young women and wanting them to look feminine.”

Yanagi added that it’s “strange” to prohibit eyeglasses for women but allow them for men.

Employees have also rallied against requirements at some companies for women to wear makeup and/or high heels.

Read more at the Fortune

Continue Reading

Headlines

Eye Health Firm Plans Job Cuts

It will focus resources on Dextenza.

mm

Published

on

BEDFORD, MA — Ocular Therapeutix Inc., a biopharmaceutical company focused on therapies for eye conditions and diseases, announced an operational restructuring plan.

The plan is expected to result in about $11 million in annualized savings through personnel reductions and $14 million in “one-time program deferrals,” according to a press release. The company did not say how many jobs would be cut.

With the restructuring, the company is looking to focus resources on Dextenza, an FDA-approved corticosteroid indicated for the treatment of ocular inflammation and pain following ophthalmic surgery.

“We have elected to restructure Ocular in order to maximize the opportunity we have with DEXTENZA and our pipeline,” said Antony Mattessich, president and CEO. “We will use a portion of the savings generated to increase the size of our commercial field force to broaden our national reach and increase DEXTENZA promotional capabilities. Additionally, the savings are anticipated to extend our cash runway through the end of 2020 and provide an improved financial position as we build the Company for the long term.”

According to the press release:

The restructuring represents a strategic realignment and commitment by the Company to allocate capital and resources to maximize the commercial opportunity of DEXTENZA® and focus resources on progressing key pipeline assets, including completion of its DEXTENZA Phase 3 trial in allergic conjunctivitis and completion of Phase 1 trials of OTX-TIC for the treatment of glaucoma and ocular hypertension and OTX-TKI for the treatment of wet age-related macular degeneration. The Company believes the savings, combined with projected sales of DEXTENZA and cash and cash equivalents, will result in an extension of the Company’s current cash runway through the fourth quarter of 2020.

Continue Reading

Headlines

FTC Releases Disclosures Guidance for Social Media Influencers

It explains when and how influencers must disclose sponsorships to their followers.

mm

Published

on

Enlisting social media “influencers” has become a popular way to promote a wide range of products, including eyewear.

Unfortunately, it’s not always obvious to consumers what is and isn’t an ad. The Federal Trade Commission wants to fix that.

The FTC has released a new publication for online influencers that lays out the agency’s rules of the road for when and how influencers must disclose sponsorships to their followers.

The new guide, “Disclosures 101 for Social Media Influencers,” provides influencers with tips from FTC staff about what triggers the need for a disclosure and offers examples of both effective and ineffective disclosures.

The guide and accompanying videos underscore that the responsibility to make disclosures about endorsements lies with the influencer. The guide outlines the various ways that an influencer’s relationship with a brand would make disclosures necessary, and it reminds influencers that they cannot assume that followers are aware of their connections to brands.

The guide includes tips for when and how influencers should tell their followers about a relationship. For example, it suggests the words influencers might use, as well as where in their social posts a disclosure should appear.

The new publication summarizes the FTC’s existing guidance in this area, including the FTC’s Endorsement Guides and a 2017 question-and-answer document produced by staff.

Continue Reading

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular